Search

everythinglearnresearchcommunity

for

Search:↓

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Testosterone metabolism in balding scalp cells may not be the main cause of hair loss.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Cetuximab can cause eyelash growth, which is rare but manageable.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

Nivolumab can cause hair loss as a rare side effect.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

Cetuximab can cause unusual hair growth and hair loss.

Scalp cooling can effectively prevent hair loss during chemotherapy, improving patients' quality of life.

Sreeparna Majumder showed incredible resilience and determination despite battling cancer.

Some chemotherapy can cause permanent hair loss.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

Cooling the scalp below 22°C before and during chemotherapy can help prevent hair loss.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

A man experienced hair loss from radiotherapy, which can be temporary or permanent depending on radiation dose, with potential treatments available.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

A woman's ovarian tumor causing high testosterone was successfully removed, and her symptoms improved.

Enlarged sweat gland ducts may indicate scarring hair loss.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

A 72-year-old man with sudden taste issues and hair growth was diagnosed with a severe stomach cancer and died within 5 months.

Higher iron levels in hair may increase the risk of esophageal cancer.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

OCT can effectively screen and diagnose various medical conditions non-invasively.